[go: up one dir, main page]

TR201009166A2 - Sefdinir içeren farmasötik bileşim için üretim yöntemi - Google Patents

Sefdinir içeren farmasötik bileşim için üretim yöntemi

Info

Publication number
TR201009166A2
TR201009166A2 TR2010/09166A TR201009166A TR201009166A2 TR 201009166 A2 TR201009166 A2 TR 201009166A2 TR 2010/09166 A TR2010/09166 A TR 2010/09166A TR 201009166 A TR201009166 A TR 201009166A TR 201009166 A2 TR201009166 A2 TR 201009166A2
Authority
TR
Turkey
Prior art keywords
production method
cefdinir
pharmaceutical composition
containing pharmaceutical
preparation
Prior art date
Application number
TR2010/09166A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/09166A priority Critical patent/TR201009166A2/tr
Priority to PCT/TR2011/000256 priority patent/WO2012060791A2/en
Publication of TR201009166A2 publication Critical patent/TR201009166A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefdinir içeren farmasötik dozaj formlarının hazırlanmasında kullanılacak bir üretim yöntemine ilişkindir.
TR2010/09166A 2010-11-05 2010-11-05 Sefdinir içeren farmasötik bileşim için üretim yöntemi TR201009166A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/09166A TR201009166A2 (tr) 2010-11-05 2010-11-05 Sefdinir içeren farmasötik bileşim için üretim yöntemi
PCT/TR2011/000256 WO2012060791A2 (en) 2010-11-05 2011-11-03 Production method for pharmaceutical compositions comprising cefdinir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09166A TR201009166A2 (tr) 2010-11-05 2010-11-05 Sefdinir içeren farmasötik bileşim için üretim yöntemi

Publications (1)

Publication Number Publication Date
TR201009166A2 true TR201009166A2 (tr) 2012-05-21

Family

ID=45524933

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09166A TR201009166A2 (tr) 2010-11-05 2010-11-05 Sefdinir içeren farmasötik bileşim için üretim yöntemi

Country Status (2)

Country Link
TR (1) TR201009166A2 (tr)
WO (1) WO2012060791A2 (tr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102935075A (zh) * 2012-11-22 2013-02-20 海南三叶美好制药有限公司 头孢地尼胶囊及其制备方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095313A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising cefdinir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
IL125214A0 (en) * 1996-02-29 1999-03-12 Fujisawa Pharmaceutical Co Beta-lactam antibiotic-containing tablet and method for producing the same
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
US20090197855A1 (en) * 2006-05-01 2009-08-06 Makarand Krishnakumar Avachat Pharmaceutical compositions of cefdinir
CN101264085A (zh) * 2007-03-14 2008-09-17 南京师范大学 含有头孢地尼环糊精包合物的药物组合物及其制备方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102935075A (zh) * 2012-11-22 2013-02-20 海南三叶美好制药有限公司 头孢地尼胶囊及其制备方法
CN102935075B (zh) * 2012-11-22 2014-02-19 海南三叶美好制药有限公司 头孢地尼胶囊及其制备方法

Also Published As

Publication number Publication date
WO2012060791A3 (en) 2012-07-26
WO2012060791A2 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
JOP20180103A1 (ar) مركب صيدلاني
EA201300388A1 (ru) Соединения замещенного бензамида
EA201270216A1 (ru) Фармацевтический состав
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
MX2011008864A (es) Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales.
IN2014MN02598A (tr)
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
EA201490320A1 (ru) Соединения тетрагидропиридопиридина и тетрагидропиридопиримидина и их применение в качестве модуляторов рецептора c5a
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201892050A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
MY173521A (en) Trpv4 antagonists
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
CO6680629A2 (es) Compuestos con actividad antibacteriana contra clsotridium
IN2014DN03245A (tr)
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.